The following article is part of conference coverage from the 2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers, in Seattle, Washington. Neurology Advisor‘s staff will be reporting breaking news associated with research conducted by leading experts in neurology. Check back for the latest news from CMSC 2019.


SEATTLE — The Multiple Sclerosis (MS) Flowsheet database has demonstrated acceptability among staff and clinicians, who cited its time savings, ability to be modified, disease-modifying therapy history awareness, test results, and relapse data as positive aspects. This research was recently presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers, held May 28 to June 1, 2019, in Seattle, Washington.

Related Articles

Clinicians, MS support staff, and research coordinators were interviewed for this study. Interviews were structured to examine use of the MS Flowsheet and to identify potential areas of improvement. With the Technology Acceptance Model as a guideline, a group of 3 researchers coded and transcribed the interviews. The technology’s barriers and facilitators were well described by the Technology Acceptance Model framework.

Items contributing to the platform’s perceived usefulness were a more efficient insurance authorization process, using time savings to increase productivity, ability to modify the platform, cohort identification, better recognition of complex patient history, support of individualized comprehensive care, and patient safety. Items contributing to perceived ease of use included system speed, ability to incorporate the system into normal workflow, similarity to the electronic health record, and ability to add and search for patients. Items contributing to attitude were subjective standards of system use by physicians and answering patient questions. For acceptance, interviewees noted the description of future usage plans following education about data and system features. Descriptions of prior use frequency and usage were included in actual use.

The study researchers conclude that “[although] the users identified some shortcomings within the system, the MS Flowsheet database was generally accepted by clinicians and staff. Time savings, awareness of disease-modifying therapy history, relapses, and test results, and the ability to modify the system were cited as common positive themes.”

Visit Neurology Advisor‘s conference section for continuous coverage from CMSC 2019.


Reference

Cooley KL, Paris B. Use of the MS flowsheet database integrated with electronic health record to support individualized multiple sclerosis comprehensive care: interviews with clinicians 3 years postimplementation. Poster presentation at: 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers; May 28-June 1, 2019; Seattle, WA. Abstract MDC06.